NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1447210380 M.D.
Verify on CMS → John Burdakin, M.D.
Hematology & Oncology Physician in Cedar Rapids, Iowa.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
264
Medicare Part D claims · Hematology & Oncology Physician avg: 885
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
John Burdakin, M.D. filed 264 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Cedar Rapids, Iowa, prescribing 81% generic.
- 264
- Part D claims, 2024
- 81%
- generic prescribing
- ≥48th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about John Burdakin, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1447210380), first enumerated 03/24/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 264 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
Compare Burdakin with other Hematology & Oncology Physician providers
Same primary specialty, same federal CMS NPPES roster.
Also enrolled in Iowa
- Dr. Anoop Aggarwal, M.D. Clinton, IA
- Dr. Saramma Alexander, MD Des Moines, IA
- Dr. Kartik Anand, MD West Des Moines, IA
- Dr. Robert Behrens, MD Des Moines, IA
- Loren Brown Des Moines, IA
- Dr. Laxmi Narayana Buddharaju, M.D. Des Moines, IA
Other specialties in Cedar Rapids: Clinical Social Worker (199) · Pharmacist (165) · Mental Health Counselor (163) · Physical Therapist (158)
CMS NPPES provider registry desk
NPI 1447210380 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1447210380
- ENUM-LEGACY 2006
- TAX-MID 12K Hematology &
- RX-LIGHT 264
- BOOK-THIN 71 in Iowa
- PHOTO-ENUM Ajit Desai, MD · 2006
John Burdakin, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
264 ≥ 48th percentile 48% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
John Burdakin, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about John Burdakin, M.D.?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
264 70% vs specialty avg
Specialty distribution in Iowa
How Hematology & Oncology Physician compares to other specialties among Iowa providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1447210380 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 03/24/2006 |
Brand vs generic prescribing mix · Typical
John Burdakin, M.D. - brand share 19.0%
Hematology & Oncology Physician average
19% brand-name claims vs 81% generic, on 264 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
264
Total Claims
$12K
Total Drug Cost
N/A
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 268.167
- Total Day Supply
- 7,532
- Brand vs Generic
- 19% brand / 81% generic
- Brand Drug Cost
- $9K
- Generic Drug Cost
- $3K
Patient Demographics
- Average Patient Age
- 82.0 years
- Avg HCC Risk Score
- 2.07
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What John Burdakin, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Simvastatin
Simvastatin
30 claims
- Xarelto
Xarelto
26 claims
- Atorvastatin Calcium
Atorvastatin Calcium
24 claims
- Baclofen
Baclofen
23 claims
- Gabapentin
Gabapentin
22 claims
- Levothyroxine Sodium
Levothyroxine Sodium
22 claims
- Allopurinol
Allopurinol
12 claims
- Carvedilol
Carvedilol
12 claims
| Drug | Claims |
|---|---|
| Simvastatin | 30 |
| Xarelto Rivaroxaban | 26 |
| Atorvastatin Calcium | 24 |
| Baclofen | 23 |
| Gabapentin | 22 |
| Levothyroxine Sodium | 22 |
| Allopurinol | 12 |
| Carvedilol | 12 |
| Donepezil Hcl | 12 |
| Memantine Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How John Burdakin, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
John Burdakin, M.D.'s 264 claims are below the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Burdakin, both outside Iowa so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Iowa
Other clinicians with the same primary specialty enrolled in Iowa, drawn from the same CMS NPPES roster as Burdakin.
One of 71 Hematology & Oncology Physician providers enrolled in Iowa, 11 are shown on this page.
Dr. Rasa Buntinas
MD
Cedar Rapids, IA
Dr. Vaughan Cipperly
MD
Mason City, IA
Raul Del Toro Mijares
Iowa City, IA
Dr. Maroun El-Khoury
MD
West Burlington, IA
Dr. Eric Engelman
D.O.
Dubuque, IA
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is John Burdakin, M.D.'s specialty? ▼
John Burdakin, M.D. specializes in Hematology & Oncology Physician and practices in Cedar Rapids, Iowa. Credentials: M.D..
How much does John Burdakin, M.D. prescribe under Medicare Part D? ▼
In 2024, John Burdakin, M.D. wrote 264 Medicare Part D claims totaling $12K in drug costs for N/A beneficiaries.
Where is John Burdakin, M.D. located? ▼
John Burdakin, M.D. is located at 600 7TH ST SE, Cedar Rapids, IA, 52401. Phone: (319) 558-0322.
What is John Burdakin, M.D.'s NPI number? ▼
John Burdakin, M.D.'s National Provider Identifier (NPI) is 1447210380, issued on 03/24/2006.
Does John Burdakin, M.D. prescribe more brand-name or generic drugs? ▼
John Burdakin, M.D.'s prescribing is 19% brand-name and 81% generic drugs by claim count, with $9K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does John Burdakin, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, John Burdakin, M.D.'s most frequently prescribed drugs include Simvastatin, Xarelto, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does John Burdakin, M.D. accept Medicare? ▼
John Burdakin, M.D. appears in CMS Medicare data with 264 Part D claims and N/A Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify John Burdakin, M.D.'s credentials? ▼
John Burdakin, M.D.'s NPI is 1447210380 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of September 2026.